nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Vismodegib—skin cancer	0.351	0.466	CbGbCtD
Gatifloxacin—ALB—Vemurafenib—skin cancer	0.278	0.368	CbGbCtD
Gatifloxacin—ALB—Fluorouracil—skin cancer	0.125	0.166	CbGbCtD
Gatifloxacin—Constipation—Vemurafenib—skin cancer	0.000542	0.0022	CcSEcCtD
Gatifloxacin—Oedema—Imiquimod—skin cancer	0.00054	0.0022	CcSEcCtD
Gatifloxacin—Infection—Imiquimod—skin cancer	0.000537	0.00218	CcSEcCtD
Gatifloxacin—Muscular weakness—Fluorouracil—skin cancer	0.000535	0.00218	CcSEcCtD
Gatifloxacin—Dysuria—Temozolomide—skin cancer	0.000532	0.00216	CcSEcCtD
Gatifloxacin—Neutropenia—Temozolomide—skin cancer	0.000532	0.00216	CcSEcCtD
Gatifloxacin—Shock—Imiquimod—skin cancer	0.000532	0.00216	CcSEcCtD
Gatifloxacin—Tachycardia—Imiquimod—skin cancer	0.000527	0.00214	CcSEcCtD
Gatifloxacin—Dysphagia—Fluorouracil—skin cancer	0.000525	0.00213	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Imiquimod—skin cancer	0.000522	0.00212	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Temozolomide—skin cancer	0.00052	0.00211	CcSEcCtD
Gatifloxacin—Anorexia—Imiquimod—skin cancer	0.000515	0.00209	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Temozolomide—skin cancer	0.000514	0.00209	CcSEcCtD
Gatifloxacin—Hepatitis—Dactinomycin—skin cancer	0.000504	0.00205	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000503	0.00205	CcSEcCtD
Gatifloxacin—Body temperature increased—Vemurafenib—skin cancer	0.000501	0.00204	CcSEcCtD
Gatifloxacin—Pharyngitis—Dactinomycin—skin cancer	0.0005	0.00203	CcSEcCtD
Gatifloxacin—Stomatitis—Temozolomide—skin cancer	0.000495	0.00201	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000492	0.002	CcSEcCtD
Gatifloxacin—Insomnia—Imiquimod—skin cancer	0.000489	0.00199	CcSEcCtD
Gatifloxacin—Paraesthesia—Imiquimod—skin cancer	0.000485	0.00197	CcSEcCtD
Gatifloxacin—Chills—Bleomycin—skin cancer	0.000485	0.00197	CcSEcCtD
Gatifloxacin—Dyspnoea—Imiquimod—skin cancer	0.000482	0.00196	CcSEcCtD
Gatifloxacin—Somnolence—Imiquimod—skin cancer	0.00048	0.00195	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Fluorouracil—skin cancer	0.000479	0.00195	CcSEcCtD
Gatifloxacin—Erythema multiforme—Dactinomycin—skin cancer	0.000476	0.00194	CcSEcCtD
Gatifloxacin—Dyspepsia—Imiquimod—skin cancer	0.000476	0.00193	CcSEcCtD
Gatifloxacin—Erythema—Bleomycin—skin cancer	0.00047	0.00191	CcSEcCtD
Gatifloxacin—Decreased appetite—Imiquimod—skin cancer	0.00047	0.00191	CcSEcCtD
Gatifloxacin—Hypersensitivity—Vemurafenib—skin cancer	0.000467	0.0019	CcSEcCtD
Gatifloxacin—Renal impairment—Docetaxel—skin cancer	0.00046	0.00187	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Docetaxel—skin cancer	0.000458	0.00186	CcSEcCtD
Gatifloxacin—Stomatitis—Fluorouracil—skin cancer	0.000456	0.00185	CcSEcCtD
Gatifloxacin—Hepatitis—Temozolomide—skin cancer	0.000456	0.00185	CcSEcCtD
Gatifloxacin—Conjunctivitis—Fluorouracil—skin cancer	0.000455	0.00185	CcSEcCtD
Gatifloxacin—Asthenia—Vemurafenib—skin cancer	0.000455	0.00185	CcSEcCtD
Gatifloxacin—Hallucination—Temozolomide—skin cancer	0.000453	0.00184	CcSEcCtD
Gatifloxacin—Pharyngitis—Temozolomide—skin cancer	0.000452	0.00184	CcSEcCtD
Gatifloxacin—Chills—Dactinomycin—skin cancer	0.000452	0.00184	CcSEcCtD
Gatifloxacin—Oedema peripheral—Temozolomide—skin cancer	0.000449	0.00182	CcSEcCtD
Gatifloxacin—Pruritus—Vemurafenib—skin cancer	0.000448	0.00182	CcSEcCtD
Gatifloxacin—Feeling abnormal—Imiquimod—skin cancer	0.000445	0.00181	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Imiquimod—skin cancer	0.000442	0.0018	CcSEcCtD
Gatifloxacin—Epistaxis—Fluorouracil—skin cancer	0.000441	0.00179	CcSEcCtD
Gatifloxacin—Visual impairment—Temozolomide—skin cancer	0.000439	0.00178	CcSEcCtD
Gatifloxacin—Erythema—Dactinomycin—skin cancer	0.000439	0.00178	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000438	0.00178	CcSEcCtD
Gatifloxacin—Diarrhoea—Vemurafenib—skin cancer	0.000433	0.00176	CcSEcCtD
Gatifloxacin—Migraine—Docetaxel—skin cancer	0.000431	0.00175	CcSEcCtD
Gatifloxacin—Erythema multiforme—Temozolomide—skin cancer	0.000431	0.00175	CcSEcCtD
Gatifloxacin—Urticaria—Imiquimod—skin cancer	0.000429	0.00174	CcSEcCtD
Gatifloxacin—Abdominal pain—Imiquimod—skin cancer	0.000427	0.00174	CcSEcCtD
Gatifloxacin—Body temperature increased—Imiquimod—skin cancer	0.000427	0.00174	CcSEcCtD
Gatifloxacin—Eye disorder—Temozolomide—skin cancer	0.000426	0.00173	CcSEcCtD
Gatifloxacin—Tinnitus—Temozolomide—skin cancer	0.000425	0.00173	CcSEcCtD
Gatifloxacin—Dizziness—Vemurafenib—skin cancer	0.000419	0.0017	CcSEcCtD
Gatifloxacin—Pharyngitis—Fluorouracil—skin cancer	0.000417	0.00169	CcSEcCtD
Gatifloxacin—Ataxia—Docetaxel—skin cancer	0.000412	0.00167	CcSEcCtD
Gatifloxacin—Chills—Temozolomide—skin cancer	0.000409	0.00166	CcSEcCtD
Gatifloxacin—Vomiting—Vemurafenib—skin cancer	0.000403	0.00164	CcSEcCtD
Gatifloxacin—Dry skin—Docetaxel—skin cancer	0.000402	0.00163	CcSEcCtD
Gatifloxacin—Chest pain—Bleomycin—skin cancer	0.0004	0.00163	CcSEcCtD
Gatifloxacin—Myalgia—Bleomycin—skin cancer	0.0004	0.00163	CcSEcCtD
Gatifloxacin—Rash—Vemurafenib—skin cancer	0.000399	0.00162	CcSEcCtD
Gatifloxacin—Dermatitis—Vemurafenib—skin cancer	0.000399	0.00162	CcSEcCtD
Gatifloxacin—Hypersensitivity—Imiquimod—skin cancer	0.000398	0.00162	CcSEcCtD
Gatifloxacin—Headache—Vemurafenib—skin cancer	0.000397	0.00161	CcSEcCtD
Gatifloxacin—Erythema—Temozolomide—skin cancer	0.000397	0.00161	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Docetaxel—skin cancer	0.000392	0.00159	CcSEcCtD
Gatifloxacin—Dysgeusia—Temozolomide—skin cancer	0.000388	0.00158	CcSEcCtD
Gatifloxacin—Asthenia—Imiquimod—skin cancer	0.000388	0.00158	CcSEcCtD
Gatifloxacin—Confusional state—Bleomycin—skin cancer	0.000387	0.00157	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000386	0.00157	CcSEcCtD
Gatifloxacin—Oedema—Bleomycin—skin cancer	0.000384	0.00156	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Bleomycin—skin cancer	0.000384	0.00156	CcSEcCtD
Gatifloxacin—Back pain—Temozolomide—skin cancer	0.000384	0.00156	CcSEcCtD
Gatifloxacin—Pruritus—Imiquimod—skin cancer	0.000382	0.00155	CcSEcCtD
Gatifloxacin—Infection—Bleomycin—skin cancer	0.000381	0.00155	CcSEcCtD
Gatifloxacin—Dysphagia—Docetaxel—skin cancer	0.000379	0.00154	CcSEcCtD
Gatifloxacin—Nausea—Vemurafenib—skin cancer	0.000376	0.00153	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Bleomycin—skin cancer	0.000376	0.00153	CcSEcCtD
Gatifloxacin—Vision blurred—Temozolomide—skin cancer	0.000374	0.00152	CcSEcCtD
Gatifloxacin—Myalgia—Dactinomycin—skin cancer	0.000373	0.00152	CcSEcCtD
Gatifloxacin—Bronchospasm—Docetaxel—skin cancer	0.000372	0.00151	CcSEcCtD
Gatifloxacin—Tremor—Temozolomide—skin cancer	0.000372	0.00151	CcSEcCtD
Gatifloxacin—Diarrhoea—Imiquimod—skin cancer	0.00037	0.0015	CcSEcCtD
Gatifloxacin—Anorexia—Bleomycin—skin cancer	0.000366	0.00149	CcSEcCtD
Gatifloxacin—Erythema—Fluorouracil—skin cancer	0.000366	0.00149	CcSEcCtD
Gatifloxacin—Agitation—Temozolomide—skin cancer	0.000365	0.00148	CcSEcCtD
Gatifloxacin—Angioedema—Temozolomide—skin cancer	0.000362	0.00147	CcSEcCtD
Gatifloxacin—Hypotension—Bleomycin—skin cancer	0.000359	0.00146	CcSEcCtD
Gatifloxacin—Oedema—Dactinomycin—skin cancer	0.000358	0.00145	CcSEcCtD
Gatifloxacin—Dizziness—Imiquimod—skin cancer	0.000357	0.00145	CcSEcCtD
Gatifloxacin—Vertigo—Temozolomide—skin cancer	0.000356	0.00145	CcSEcCtD
Gatifloxacin—Infection—Dactinomycin—skin cancer	0.000356	0.00145	CcSEcCtD
Gatifloxacin—Neutropenia—Docetaxel—skin cancer	0.000354	0.00144	CcSEcCtD
Gatifloxacin—Palpitations—Temozolomide—skin cancer	0.000351	0.00142	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Dactinomycin—skin cancer	0.00035	0.00142	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00035	0.00142	CcSEcCtD
Gatifloxacin—Paraesthesia—Bleomycin—skin cancer	0.000345	0.0014	CcSEcCtD
Gatifloxacin—Vision blurred—Fluorouracil—skin cancer	0.000344	0.0014	CcSEcCtD
Gatifloxacin—Convulsion—Temozolomide—skin cancer	0.000344	0.0014	CcSEcCtD
Gatifloxacin—Vomiting—Imiquimod—skin cancer	0.000344	0.0014	CcSEcCtD
Gatifloxacin—Hypertension—Temozolomide—skin cancer	0.000343	0.00139	CcSEcCtD
Gatifloxacin—Dyspnoea—Bleomycin—skin cancer	0.000342	0.00139	CcSEcCtD
Gatifloxacin—Anorexia—Dactinomycin—skin cancer	0.000341	0.00139	CcSEcCtD
Gatifloxacin—Rash—Imiquimod—skin cancer	0.000341	0.00138	CcSEcCtD
Gatifloxacin—Dermatitis—Imiquimod—skin cancer	0.00034	0.00138	CcSEcCtD
Gatifloxacin—Headache—Imiquimod—skin cancer	0.000338	0.00138	CcSEcCtD
Gatifloxacin—Arthralgia—Temozolomide—skin cancer	0.000338	0.00137	CcSEcCtD
Gatifloxacin—Myalgia—Temozolomide—skin cancer	0.000338	0.00137	CcSEcCtD
Gatifloxacin—Anxiety—Temozolomide—skin cancer	0.000337	0.00137	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000335	0.00136	CcSEcCtD
Gatifloxacin—Decreased appetite—Bleomycin—skin cancer	0.000334	0.00136	CcSEcCtD
Gatifloxacin—Stomatitis—Docetaxel—skin cancer	0.000329	0.00134	CcSEcCtD
Gatifloxacin—Conjunctivitis—Docetaxel—skin cancer	0.000328	0.00133	CcSEcCtD
Gatifloxacin—Confusional state—Temozolomide—skin cancer	0.000326	0.00133	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000326	0.00133	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Temozolomide—skin cancer	0.000324	0.00132	CcSEcCtD
Gatifloxacin—Oedema—Temozolomide—skin cancer	0.000324	0.00132	CcSEcCtD
Gatifloxacin—Infection—Temozolomide—skin cancer	0.000322	0.00131	CcSEcCtD
Gatifloxacin—Nausea—Imiquimod—skin cancer	0.000321	0.0013	CcSEcCtD
Gatifloxacin—Epistaxis—Docetaxel—skin cancer	0.000318	0.00129	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Temozolomide—skin cancer	0.000317	0.00129	CcSEcCtD
Gatifloxacin—Convulsion—Fluorouracil—skin cancer	0.000317	0.00129	CcSEcCtD
Gatifloxacin—Feeling abnormal—Bleomycin—skin cancer	0.000316	0.00129	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Temozolomide—skin cancer	0.000313	0.00127	CcSEcCtD
Gatifloxacin—Chest pain—Fluorouracil—skin cancer	0.000311	0.00126	CcSEcCtD
Gatifloxacin—Myalgia—Fluorouracil—skin cancer	0.000311	0.00126	CcSEcCtD
Gatifloxacin—Decreased appetite—Dactinomycin—skin cancer	0.000311	0.00126	CcSEcCtD
Gatifloxacin—Anorexia—Temozolomide—skin cancer	0.000309	0.00125	CcSEcCtD
Gatifloxacin—Urticaria—Bleomycin—skin cancer	0.000305	0.00124	CcSEcCtD
Gatifloxacin—Body temperature increased—Bleomycin—skin cancer	0.000303	0.00123	CcSEcCtD
Gatifloxacin—Hepatitis—Docetaxel—skin cancer	0.000303	0.00123	CcSEcCtD
Gatifloxacin—Confusional state—Fluorouracil—skin cancer	0.000301	0.00122	CcSEcCtD
Gatifloxacin—Pharyngitis—Docetaxel—skin cancer	0.000301	0.00122	CcSEcCtD
Gatifloxacin—Oedema peripheral—Docetaxel—skin cancer	0.000299	0.00121	CcSEcCtD
Gatifloxacin—Oedema—Fluorouracil—skin cancer	0.000298	0.00121	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Fluorouracil—skin cancer	0.000298	0.00121	CcSEcCtD
Gatifloxacin—Infection—Fluorouracil—skin cancer	0.000296	0.0012	CcSEcCtD
Gatifloxacin—Feeling abnormal—Dactinomycin—skin cancer	0.000295	0.0012	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000295	0.0012	CcSEcCtD
Gatifloxacin—Insomnia—Temozolomide—skin cancer	0.000293	0.00119	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000293	0.00119	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Fluorouracil—skin cancer	0.000292	0.00119	CcSEcCtD
Gatifloxacin—Visual impairment—Docetaxel—skin cancer	0.000292	0.00119	CcSEcCtD
Gatifloxacin—Tachycardia—Fluorouracil—skin cancer	0.000291	0.00118	CcSEcCtD
Gatifloxacin—Paraesthesia—Temozolomide—skin cancer	0.000291	0.00118	CcSEcCtD
Gatifloxacin—Dyspnoea—Temozolomide—skin cancer	0.000289	0.00117	CcSEcCtD
Gatifloxacin—Somnolence—Temozolomide—skin cancer	0.000288	0.00117	CcSEcCtD
Gatifloxacin—Erythema multiforme—Docetaxel—skin cancer	0.000287	0.00116	CcSEcCtD
Gatifloxacin—Dyspepsia—Temozolomide—skin cancer	0.000285	0.00116	CcSEcCtD
Gatifloxacin—Anorexia—Fluorouracil—skin cancer	0.000284	0.00116	CcSEcCtD
Gatifloxacin—Eye disorder—Docetaxel—skin cancer	0.000283	0.00115	CcSEcCtD
Gatifloxacin—Body temperature increased—Dactinomycin—skin cancer	0.000283	0.00115	CcSEcCtD
Gatifloxacin—Abdominal pain—Dactinomycin—skin cancer	0.000283	0.00115	CcSEcCtD
Gatifloxacin—Hypersensitivity—Bleomycin—skin cancer	0.000283	0.00115	CcSEcCtD
Gatifloxacin—Decreased appetite—Temozolomide—skin cancer	0.000281	0.00114	CcSEcCtD
Gatifloxacin—Hypotension—Fluorouracil—skin cancer	0.000279	0.00113	CcSEcCtD
Gatifloxacin—Constipation—Temozolomide—skin cancer	0.000277	0.00113	CcSEcCtD
Gatifloxacin—Asthenia—Bleomycin—skin cancer	0.000275	0.00112	CcSEcCtD
Gatifloxacin—Chills—Docetaxel—skin cancer	0.000272	0.00111	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000272	0.0011	CcSEcCtD
Gatifloxacin—Pruritus—Bleomycin—skin cancer	0.000272	0.0011	CcSEcCtD
Gatifloxacin—Insomnia—Fluorouracil—skin cancer	0.00027	0.0011	CcSEcCtD
Gatifloxacin—Paraesthesia—Fluorouracil—skin cancer	0.000268	0.00109	CcSEcCtD
Gatifloxacin—Feeling abnormal—Temozolomide—skin cancer	0.000267	0.00108	CcSEcCtD
Gatifloxacin—Dyspnoea—Fluorouracil—skin cancer	0.000266	0.00108	CcSEcCtD
Gatifloxacin—Somnolence—Fluorouracil—skin cancer	0.000265	0.00108	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Temozolomide—skin cancer	0.000265	0.00108	CcSEcCtD
Gatifloxacin—Erythema—Docetaxel—skin cancer	0.000264	0.00107	CcSEcCtD
Gatifloxacin—Hypersensitivity—Dactinomycin—skin cancer	0.000264	0.00107	CcSEcCtD
Gatifloxacin—Dyspepsia—Fluorouracil—skin cancer	0.000263	0.00107	CcSEcCtD
Gatifloxacin—Decreased appetite—Fluorouracil—skin cancer	0.000259	0.00105	CcSEcCtD
Gatifloxacin—Dysgeusia—Docetaxel—skin cancer	0.000258	0.00105	CcSEcCtD
Gatifloxacin—Urticaria—Temozolomide—skin cancer	0.000257	0.00105	CcSEcCtD
Gatifloxacin—Asthenia—Dactinomycin—skin cancer	0.000257	0.00104	CcSEcCtD
Gatifloxacin—Abdominal pain—Temozolomide—skin cancer	0.000256	0.00104	CcSEcCtD
Gatifloxacin—Body temperature increased—Temozolomide—skin cancer	0.000256	0.00104	CcSEcCtD
Gatifloxacin—Back pain—Docetaxel—skin cancer	0.000255	0.00104	CcSEcCtD
Gatifloxacin—Muscle spasms—Docetaxel—skin cancer	0.000254	0.00103	CcSEcCtD
Gatifloxacin—Feeling abnormal—Fluorouracil—skin cancer	0.000246	0.000999	CcSEcCtD
Gatifloxacin—Diarrhoea—Dactinomycin—skin cancer	0.000245	0.000995	CcSEcCtD
Gatifloxacin—Vomiting—Bleomycin—skin cancer	0.000244	0.000992	CcSEcCtD
Gatifloxacin—Rash—Bleomycin—skin cancer	0.000242	0.000984	CcSEcCtD
Gatifloxacin—Dermatitis—Bleomycin—skin cancer	0.000242	0.000983	CcSEcCtD
Gatifloxacin—Hypersensitivity—Temozolomide—skin cancer	0.000239	0.000969	CcSEcCtD
Gatifloxacin—Urticaria—Fluorouracil—skin cancer	0.000237	0.000963	CcSEcCtD
Gatifloxacin—Syncope—Docetaxel—skin cancer	0.000237	0.000961	CcSEcCtD
Gatifloxacin—Body temperature increased—Fluorouracil—skin cancer	0.000236	0.000958	CcSEcCtD
Gatifloxacin—Palpitations—Docetaxel—skin cancer	0.000233	0.000947	CcSEcCtD
Gatifloxacin—Asthenia—Temozolomide—skin cancer	0.000232	0.000944	CcSEcCtD
Gatifloxacin—Loss of consciousness—Docetaxel—skin cancer	0.000232	0.000942	CcSEcCtD
Gatifloxacin—Pruritus—Temozolomide—skin cancer	0.000229	0.000931	CcSEcCtD
Gatifloxacin—Convulsion—Docetaxel—skin cancer	0.000229	0.000929	CcSEcCtD
Gatifloxacin—Nausea—Bleomycin—skin cancer	0.000228	0.000927	CcSEcCtD
Gatifloxacin—Hypertension—Docetaxel—skin cancer	0.000228	0.000926	CcSEcCtD
Gatifloxacin—Vomiting—Dactinomycin—skin cancer	0.000228	0.000925	CcSEcCtD
Gatifloxacin—Rash—Dactinomycin—skin cancer	0.000226	0.000917	CcSEcCtD
Gatifloxacin—Chest pain—Docetaxel—skin cancer	0.000225	0.000913	CcSEcCtD
Gatifloxacin—Myalgia—Docetaxel—skin cancer	0.000225	0.000913	CcSEcCtD
Gatifloxacin—Arthralgia—Docetaxel—skin cancer	0.000225	0.000913	CcSEcCtD
Gatifloxacin—Diarrhoea—Temozolomide—skin cancer	0.000222	0.0009	CcSEcCtD
Gatifloxacin—Hypersensitivity—Fluorouracil—skin cancer	0.00022	0.000893	CcSEcCtD
Gatifloxacin—Confusional state—Docetaxel—skin cancer	0.000217	0.000882	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Docetaxel—skin cancer	0.000215	0.000875	CcSEcCtD
Gatifloxacin—Oedema—Docetaxel—skin cancer	0.000215	0.000875	CcSEcCtD
Gatifloxacin—Dizziness—Temozolomide—skin cancer	0.000214	0.00087	CcSEcCtD
Gatifloxacin—Infection—Docetaxel—skin cancer	0.000214	0.000869	CcSEcCtD
Gatifloxacin—Nausea—Dactinomycin—skin cancer	0.000213	0.000864	CcSEcCtD
Gatifloxacin—Shock—Docetaxel—skin cancer	0.000212	0.000861	CcSEcCtD
Gatifloxacin—Pruritus—Fluorouracil—skin cancer	0.000211	0.000858	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Docetaxel—skin cancer	0.000211	0.000857	CcSEcCtD
Gatifloxacin—Tachycardia—Docetaxel—skin cancer	0.00021	0.000854	CcSEcCtD
Gatifloxacin—Vomiting—Temozolomide—skin cancer	0.000206	0.000837	CcSEcCtD
Gatifloxacin—Anorexia—Docetaxel—skin cancer	0.000205	0.000834	CcSEcCtD
Gatifloxacin—Rash—Temozolomide—skin cancer	0.000204	0.00083	CcSEcCtD
Gatifloxacin—Diarrhoea—Fluorouracil—skin cancer	0.000204	0.00083	CcSEcCtD
Gatifloxacin—Dermatitis—Temozolomide—skin cancer	0.000204	0.000829	CcSEcCtD
Gatifloxacin—Headache—Temozolomide—skin cancer	0.000203	0.000824	CcSEcCtD
Gatifloxacin—Hypotension—Docetaxel—skin cancer	0.000201	0.000818	CcSEcCtD
Gatifloxacin—Dizziness—Fluorouracil—skin cancer	0.000197	0.000802	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000196	0.000797	CcSEcCtD
Gatifloxacin—Insomnia—Docetaxel—skin cancer	0.000195	0.000791	CcSEcCtD
Gatifloxacin—Paraesthesia—Docetaxel—skin cancer	0.000193	0.000786	CcSEcCtD
Gatifloxacin—Nausea—Temozolomide—skin cancer	0.000192	0.000782	CcSEcCtD
Gatifloxacin—Dyspnoea—Docetaxel—skin cancer	0.000192	0.00078	CcSEcCtD
Gatifloxacin—Somnolence—Docetaxel—skin cancer	0.000191	0.000778	CcSEcCtD
Gatifloxacin—Vomiting—Fluorouracil—skin cancer	0.00019	0.000771	CcSEcCtD
Gatifloxacin—Dyspepsia—Docetaxel—skin cancer	0.00019	0.00077	CcSEcCtD
Gatifloxacin—Rash—Fluorouracil—skin cancer	0.000188	0.000764	CcSEcCtD
Gatifloxacin—Dermatitis—Fluorouracil—skin cancer	0.000188	0.000764	CcSEcCtD
Gatifloxacin—Decreased appetite—Docetaxel—skin cancer	0.000187	0.000761	CcSEcCtD
Gatifloxacin—Headache—Fluorouracil—skin cancer	0.000187	0.000759	CcSEcCtD
Gatifloxacin—Constipation—Docetaxel—skin cancer	0.000184	0.000748	CcSEcCtD
Gatifloxacin—Feeling abnormal—Docetaxel—skin cancer	0.000177	0.000721	CcSEcCtD
Gatifloxacin—Nausea—Fluorouracil—skin cancer	0.000177	0.00072	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Docetaxel—skin cancer	0.000176	0.000716	CcSEcCtD
Gatifloxacin—Abdominal pain—Docetaxel—skin cancer	0.00017	0.000692	CcSEcCtD
Gatifloxacin—Body temperature increased—Docetaxel—skin cancer	0.00017	0.000692	CcSEcCtD
Gatifloxacin—Hypersensitivity—Docetaxel—skin cancer	0.000159	0.000645	CcSEcCtD
Gatifloxacin—Asthenia—Docetaxel—skin cancer	0.000154	0.000628	CcSEcCtD
Gatifloxacin—Pruritus—Docetaxel—skin cancer	0.000152	0.000619	CcSEcCtD
Gatifloxacin—Diarrhoea—Docetaxel—skin cancer	0.000147	0.000599	CcSEcCtD
Gatifloxacin—Dizziness—Docetaxel—skin cancer	0.000142	0.000579	CcSEcCtD
Gatifloxacin—Vomiting—Docetaxel—skin cancer	0.000137	0.000556	CcSEcCtD
Gatifloxacin—Rash—Docetaxel—skin cancer	0.000136	0.000552	CcSEcCtD
Gatifloxacin—Dermatitis—Docetaxel—skin cancer	0.000136	0.000551	CcSEcCtD
Gatifloxacin—Headache—Docetaxel—skin cancer	0.000135	0.000548	CcSEcCtD
Gatifloxacin—Nausea—Docetaxel—skin cancer	0.000128	0.00052	CcSEcCtD
